Cardio Diagnostics Holdings, Inc.
CDIO- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001870144
No open-market purchases or sales by Cardio Diagnostics Holdings, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $422.7K in total; no superinvestor holds it.
Other share classesCDIOW
Q1 2024 vs. Q4 2023
How the institutions holding Cardio Diagnostics Holdings, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 14 | 14 | 0 |
| Shares | 1.66M | 1.62M | −33.7K (−2.0%) |
| Value | $4.12M | $2.30M | −$1.82M (−44.1%) |
New holders (2)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 16,927 | $24.0K | 0.00% |
| UBS Group AG | 12,520 | $17.8K | 0.00% |
Sold out (2)
Institutions that held Cardio Diagnostics Holdings, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Linden Advisors LP | 45,618 | $113.6K |
| Squarepoint Ops LLC | 39,105 | $97.4K |